Brainsway Ltd (NASDAQ:BWAY) Q2 2023 Earnings Conference Call August 9, 2023 8:30 AM ET
Company Participants
Brian Ritchie - LifeSci Advisors
Hadar Levy - CEO
Ido Marom - CFO
Conference Call Participants
Jeffrey Cohen - Ladenburg Thalmann & Co.
Jayson Bedford - Raymond James & Associates
Steven Lichtman - Oppenheimer
Boobalan Pachaiyappan - H.C. Wainwright & Co.
Operator
Good morning, ladies and gentlemen. And welcome to the BrainsWay Second Quarter 2023 Earnings Conference Call. [Operator Instructions]. This call is being recorded on Wednesday, August 9, 2023. I would now like to turn the conference over to Brian Ritchie with LifeSci. Please go ahead, sir.
Brian Ritchie
Thank you. And welcome to BrainsWay's Second Quarter 2023 Earnings Conference Call. With us today are BrainsWay's Chief Executive Officer, Hadar Levy, and Chief Financial Officer; Ido Marom. The format for today's call will be a discussion of recent trends and business updates from Hadar, followed by a detailed discussion of the financials. Then we will open up the call for your questions. Earlier today, BrainsWay released financial results for the 3 and 6 months ended June 30, 2023.
A copy of the press release is available on the company's Investor Relations website. Before I turn the call over to Hadar, I would like to remind you that this conference call, including both management's prepared remarks and the question-and-answer session may contain projections or other forward-looking statements regarding, among other topics, BrainsWay's anticipated future operating and financial performance, business plans and prospects and expectations for its products and pipeline which are all subject to risks and uncertainties, including shifting market conditions resulting from the COVID-19 pandemic, the global supply chain crisis as well as the use of non-GAAP financial information.
Additional information regarding these and other risks are available in the company's earnings release and its other filings with the SEC, including the Risk Factors section contained in BrainsWay's Form 20-F I would now like to turn the call over to Hadar.
Hadar Levy
Thank you, Brian. Welcome, everyone, and thank you for joining us today. I'm pleased to report that our efforts toward implementing key initiatives aimed at growing the company's top line over 2022, while targeting breakeven operating income and positive adjusted EBITDA in the fourth quarter, are progressing extremely well. We remain focused on optimizing our existing commercial process, including enhancing our emphasized on larger institutionals and enterprise customers that are playing an increasingly important role within the industry.